AsoNevus supports European research in 2023
Channel: Congenital melanocytic nevus research
Date: 2023-04-07

For many years, AsoNevus has funded basic research into causes and models of the rare disease, the large and giant congenital melanocytic nevus (CMN). This team from a medical genetics laboratory in Marseille, France, led by Dr. Heather Etchevers, presents its projects for 2023 at the annual family gathering in Saragoza in April.
Download a translation of this talk to read along: https://amubox.univ-amu.fr/s/sTYC5tgZrGHrCLF
For more information, please see the laboratory's website at https://www.marseille-medical-genetics.org/h-etchevers/ and feel free to contact us. We encourage all viewers to find out more about the greater European consortium that was made possible by AsoNevus and other patient advocacy group support, called MELCAYA (Melanoma in Children, Adolescents and Young Adults). This international team, with collaborators around the world and leadership based in Barcelona, Spain, studies an extremely rare and understudied cancer that is more often found in young people with CMN than the general population. Dr. Etchevers organizes the basic research part of this initiative, and more information about the partners and goals can be found here: https://cordis.europa.eu/project/id/101096667